Despite increasing numbers of cancer drugs being licensed, an analysis has found that highly innovative drugs took longer to reach NHS patients than more conventional treatments.

Data from a clinical trial which assessed the benefits of adding chemotherapy alongside radiotherapy for patients with muscle invasive bladder cancer has shown that this treatment can be given without substantially impacting subsequent health related quality of life.

Aggressive, highly mutated cancers evolve escape routes in response to immune attacks in an ‘evolutionary arms race’ between cancer and the immune system, a new study reports.